Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 7Active not recruiting 4Unknown 1Terminated 1Suspended 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 11Gastrointestinal 6Genitourinary 5Sarcoma 4CNS 4Breast 4Lymphoid 3Head & Neck 3Other hematologic neoplasm 2Myeloid 2Endocrine 2Dermatologic 2Plasma cell 1Other neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1

Interventions

Paclitaxel 263Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × X-Rays × Gynecologic × Clear all
NCT02206048 2022-07-25

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

M.D. Anderson Cancer Center

Phase NA Completed
9 enrolled 5 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡